Shape Memory Medical Inc. completed $38 million in Series C financing led by Earlybird Venture Capital and with the participation of new and existing investors to advance endovascular embolization technology.

Shape Memory Medical Inc. completed a $38 million Series C round led by Earlybird Venture Capital for advancing the clinical and market development of shape memory polymer technology for aortic and peripheral vascular markets. The funding will also support the research and development of their product pipeline and the expansion of sales and marketing strategies.